| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Joint Diseases Laboratory,*
Shriners Hospital
for Children, Division of Surgical Research, Department of Surgery,
McGill University, Montreal, Quebec, Canada, and Orthopedic Research
Laboratories,
Montefiore Hospital Medical
Center, Bronx Medical Center, Bronx, New York
Both type II collagen and the proteoglycan aggrecan are capable of inducing an erosive inflammatory polyarthritis in mice. In this study we provide the first demonstration that link protein (LP), purified from bovine cartilage, can produce a persistent, erosive, inflammatory polyarthritis when injected repeatedly intraperitoneally into BALB/c mice. We discovered a single T-cell epitope, located within residues 266 to 290 of bovine LP (NDGAQIAKVGQIFAAWKLLGYDRCD), which is recognized by bovine LP-specific T lymphocytes. We also identified three immunogenic regions in bovine LP that contain epitopes recognized by antibodies in hyperimmunized sera. One of these B-cell regions is found in the most species-variable domain of LP (residues 1 to 36), whereas the other epitopes are located in the most conserved regions (residues 186 to 230 and 286 to 310). The latter two regions contain an AGWLSDGSVQYP motif shared by the G1 globulin domain of aggrecan core protein, versican, neurocan, glial hyaluronan-binding protein, and the hyaluronan receptor CD44. Our data reveal that the induction of arthritis is associated with antibody reactivities to B-cell epitopes located at residues 1 to 19. Together, these observations show that another cartilage protein, LP, like type II collagen and the proteoglycan aggrecan, is capable of inducing an erosive inflammatory arthritis in mice and that the immunity to LP involves recognition of both T- and B-cell epitopes. This immunity may be of importance in the pathogenesis of inflammatory joint diseases, such as juvenile rheumatoid arthritis, in which cellular immunity to LP has been demonstrated.
This article has been cited by other articles:
 |
|
 |
|
  R.-R. Da, Y. Qin, D. Baeten, and Y. Zhang B Cell Clonal Expansion and Somatic Hypermutation of Ig Variable Heavy Chain Genes in the Synovial Membrane of Patients with Osteoarthritis J. Immunol., January 1, 2007; 178(1): 557 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Kuon, M. Kuhne, D. H. Busch, P. Atagunduz, M. Seipel, P. Wu, L. Morawietz, G. Fernahl, H. Appel, E. H. Weiss, et al. Identification of Novel Human Aggrecan T Cell Epitopes in HLA-B27 Transgenic Mice Associated with Spondyloarthropathy J. Immunol., October 15, 2004; 173(8): 4859 - 4866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Milz, T Tischer, A Buettner, M Schieker, M Maier, S Redman, P Emery, D McGonagle, and M Benjamin Molecular composition and pathology of entheses on the medial and lateral epicondyles of the humerus: a structural basis for epicondylitis Ann Rheum Dis, September 1, 2004; 63(9): 1015 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Milz, F. Regner, R. Putz, and M. Benjamin Expression of a Wide Range of Extracellular Matrix Molecules in the Tendon and Trochlea of the Human Superior Oblique Muscle Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1330 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F. Rosloniec, K. B. Whittington, D. M. Zaller, and A. H. Kang HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) Use the Same Anchor Residues for Binding an Immunodominant Peptide Derived from Human Type II Collagen J. Immunol., January 1, 2002; 168(1): 253 - 259. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
